Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives
Go back to Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 58.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.44 | 52 Week High | $3.48 | |||
| Open | $58.44 | 52 Week Low | $0.80 | |||
| Day High | $58.44 | P/E | N/A | |||
| Day Low | $58.44 | EPS | $-1.54 | |||
| Volume | 15 | |||||
